Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Mass immunization of children has the potential to decrease infection rates and prevent the transmission of influenza. We evaluated the immunogenicity, safety, and tolerability of different formulations of cell-derived MF59-adjuvanted and nonadjuvanted A/H1N1 influenza vaccine in children and adoles...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Vaccin Immunother
Egile Nagusiak: Knuf, Markus, Leroux-Roels, Geert, Rümke, Hans, Rivera, Luis, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria, Kieninger, Dorothee, Cioppa, Giovanni Della
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2015
Gaiak:
INFLUENZA/Research Papers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514327/
https://ncbi.nlm.nih.gov/pubmed/25621884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.987014
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak